In a regulatory filing, SpringWorks Therapeutics (SWTX) disclosed that its CEO Saqim Islam sold 48K shares of common stock on February 10th in a total transaction size of $2.56M.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SWTX:
- Biotech Alert: Searches spiking for these stocks today
- Wedbush ups SpringWorks target to $81, expects Merck KGaA ‘official’ offer soon
- SpringWorks sets wholesale acquisition cost for Gomekli at $206.25 per mg
- SpringWorks Therapeutics sets wholesale acquisition cost for GOMEKLI at $206.25
- SpringWorks Therapeutics price target raised to $66 from $63 at TD Cowen